← Back to all clusters

Cluster 177

9 diseases · 26 shared-gene connections
9 Diseases
2 Unique genes
0.462 Avg. similarity score
Corticosterone methyl oxidase type i Most-connected disease (7 links)
Log in to save this analysis

Save This Analysis

Disease Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details · click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) · drag a node to pin it in place · scroll/pinch to zoom.

Member diseases (most connected first ‐ the cluster's core)

Top shared genes (genes linked to 2+ member diseases)

Gene ⇵ Member diseases ⇵ Linked diseases
CYP11B2 8 / 9 Corticosterone methyl oxidase type i, Corticosterone methyloxidase deficiency, Corticosterone monooxygenase deficiency, familial hyperreninemic hypoaldosteronism type 2 and 4 more
CYP11B1 2 / 9 Glucocorticoid-remediable aldosteronism, Steroid 11-beta-monooxygenase deficiency
What do these columns mean?
Connections in cluster
How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
Significant partners
How many of those links are statistically significant (FDR q < 0.05).
Curated genes
Distinct curated genes linked to that disease in GeDiPNet.
Member diseases (Top shared genes)
How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
Overlap genes (x / y)
x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
Cluster gene count
Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
Fold enrichment
Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
P-value / FDR q-value
Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
Shared genes (Pairs within this cluster)
Number of curated genes the two diseases in that row have in common.
Similarity score (Pairs within this cluster)
Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.

Enriched Pathways (why this cluster is grouped, biologically)

Pathway ⇵ Source ⇵ Overlap genes ⇵ Fold enrichment ⇵ P-value ⇵ FDR q-value ⇵
Glucocorticoid biosynthesis Reactome 2 / 10 1,201× 6.24e-7 3.23e-5 ✓ sig.
Endogenous sterols Reactome 2 / 25 480× 4.16e-6 1.63e-4 ✓ sig.
Steroid hormone biosynthesis KEGG 2 / 63 191× 2.71e-5 7.65e-4 ✓ sig.
Defective CYP11B1 causes Adrenal hyperplasia 4 (AH4) Reactome 1 / 1 6,005× 1.67e-4 3.38e-3 ✓ sig.
Defective CYP11B2 causes Corticosterone methyloxidase 1 deficiency (CMO-1 deficiency) Reactome 1 / 1 6,005× 1.67e-4 3.38e-3 ✓ sig.
Mineralocorticoid biosynthesis Reactome 1 / 6 1,001× 9.99e-4 1.35e-2 ✓ sig.
Cortisol synthesis and secretion KEGG 1 / 65 92.4× 1.08e-2 7.19e-2
Aldosterone synthesis and secretion KEGG 1 / 98 61.3× 1.63e-2 9.14e-2
Metabolic pathways KEGG 2 / 1,563 7.7× 1.69e-2 9.38e-2
Cushing syndrome KEGG 1 / 155 38.7× 2.56e-2 1.18e-1

Enriched GO Terms (Biological Process, a second line of biological evidence)

GO term ⇵ GO ID ⇵ Overlap genes ⇵ Fold enrichment ⇵ P-value ⇵ FDR q-value ⇵
aldosterone biosynthetic process GO:0032342 2 / 3 6,229× 1.72e-8 2.73e-6 ✓ sig.
cortisol metabolic process GO:0034650 2 / 4 4,672× 3.44e-8 4.93e-6 ✓ sig.
cortisol biosynthetic process GO:0034651 2 / 5 3,737× 5.73e-8 7.60e-6 ✓ sig.
C21-steroid hormone biosynthetic process GO:0006700 2 / 5 3,737× 5.73e-8 7.60e-6 ✓ sig.
glucocorticoid biosynthetic process GO:0006704 2 / 7 2,670× 1.20e-7 1.41e-5 ✓ sig.
cellular response to potassium ion GO:0035865 2 / 14 1,335× 5.21e-7 4.84e-5 ✓ sig.
alcohol metabolic process GO:0006066 2 / 18 1,038× 8.76e-7 7.44e-5 ✓ sig.
cellular response to peptide hormone stimulus GO:0071375 2 / 18 1,038× 8.76e-7 7.44e-5 ✓ sig.
sterol metabolic process GO:0016125 2 / 22 849× 1.32e-6 1.03e-4 ✓ sig.
cellular response to hormone stimulus GO:0032870 2 / 48 389× 6.46e-6 3.68e-4 ✓ sig.
steroid biosynthetic process GO:0006694 2 / 65 287× 1.19e-5 5.97e-4 ✓ sig.
cholesterol metabolic process GO:0008203 2 / 107 175× 3.25e-5 1.30e-3 ✓ sig.
regulation of blood volume by renal aldosterone GO:0002017 1 / 2 4,672× 2.14e-4 5.28e-3 ✓ sig.
mineralocorticoid biosynthetic process GO:0006705 1 / 2 4,672× 2.14e-4 5.28e-3 ✓ sig.
lipid metabolic process GO:0006629 2 / 840 22.2× 2.02e-3 2.27e-2 ✓ sig.

Pairs within this cluster, by significance

Disease A ⇵ Disease B ⇵ Similarity score ⇵ Shared genes ⇵ P-value ⇵ FDR q-value ⇵
Corticosterone methyl oxidase type i Corticosterone methyloxidase deficiency 0.500 1 6.49e-5 2.34e-4 ✓ sig.
Hyperreninemic hypoaldosteronism Hypoaldosteronism 0.500 1 6.49e-5 2.34e-4 ✓ sig.
Familial hypoaldosteronism Hypoaldosteronism 0.500 1 6.49e-5 2.34e-4 ✓ sig.
Familial hypoaldosteronism Hyperreninemic hypoaldosteronism 0.500 1 6.49e-5 2.34e-4 ✓ sig.
familial hyperreninemic hypoaldosteronism type 2 Hyperreninemic hypoaldosteronism 0.500 1 6.49e-5 2.34e-4 ✓ sig.
familial hyperreninemic hypoaldosteronism type 2 Familial hypoaldosteronism 0.500 1 6.49e-5 2.34e-4 ✓ sig.
Corticosterone methyloxidase deficiency familial hyperreninemic hypoaldosteronism type 2 0.500 1 6.49e-5 2.34e-4 ✓ sig.
Corticosterone monooxygenase deficiency familial hyperreninemic hypoaldosteronism type 2 0.500 1 6.49e-5 2.34e-4 ✓ sig.
Corticosterone methyl oxidase type i familial hyperreninemic hypoaldosteronism type 2 0.500 1 6.49e-5 2.34e-4 ✓ sig.
Corticosterone monooxygenase deficiency Hypoaldosteronism 0.500 1 6.49e-5 2.34e-4 ✓ sig.
Corticosterone monooxygenase deficiency Hyperreninemic hypoaldosteronism 0.500 1 6.49e-5 2.34e-4 ✓ sig.
Corticosterone monooxygenase deficiency Familial hypoaldosteronism 0.500 1 6.49e-5 2.34e-4 ✓ sig.
Corticosterone methyloxidase deficiency Hypoaldosteronism 0.500 1 6.49e-5 2.34e-4 ✓ sig.
Corticosterone methyloxidase deficiency Hyperreninemic hypoaldosteronism 0.500 1 6.49e-5 2.34e-4 ✓ sig.
Corticosterone methyloxidase deficiency Familial hypoaldosteronism 0.500 1 6.49e-5 2.34e-4 ✓ sig.
Corticosterone methyloxidase deficiency Corticosterone monooxygenase deficiency 0.500 1 6.49e-5 2.34e-4 ✓ sig.
Corticosterone methyl oxidase type i Hypoaldosteronism 0.500 1 6.49e-5 2.34e-4 ✓ sig.
Corticosterone methyl oxidase type i Hyperreninemic hypoaldosteronism 0.500 1 6.49e-5 2.34e-4 ✓ sig.
Corticosterone methyl oxidase type i Familial hypoaldosteronism 0.500 1 6.49e-5 2.34e-4 ✓ sig.
Corticosterone methyl oxidase type i Corticosterone monooxygenase deficiency 0.500 1 6.49e-5 2.34e-4 ✓ sig.
Corticosterone methyl oxidase type i Glucocorticoid-remediable aldosteronism 0.333 1 1.30e-4 3.90e-4 ✓ sig.
Corticosterone monooxygenase deficiency Glucocorticoid-remediable aldosteronism 0.333 1 1.30e-4 3.90e-4 ✓ sig.
Corticosterone methyloxidase deficiency Glucocorticoid-remediable aldosteronism 0.333 1 1.30e-4 3.90e-4 ✓ sig.
Familial hypoaldosteronism Glucocorticoid-remediable aldosteronism 0.333 1 1.30e-4 3.90e-4 ✓ sig.
Glucocorticoid-remediable aldosteronism Hyperreninemic hypoaldosteronism 0.333 1 1.30e-4 3.90e-4 ✓ sig.
Glucocorticoid-remediable aldosteronism Steroid 11-beta-monooxygenase deficiency 0.333 1 1.30e-4 3.90e-4 ✓ sig.